Nephros
NEPH
8 hedge funds and large institutions have $2.09M invested in Nephros in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
3.37% more ownership
Funds ownership: 0% → 3.37% (+3.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Southpaw Asset Management
Stamford,
Connecticut
|
+$541K |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$482K |
| 3 |
Millennium Management
New York
|
+$282K |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$251K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$192K |
Top Sellers
NEPH Hedge Fund Activity: Q3 2019 in Review
8 of the 4,575 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2019, worth a combined $2.09M.
Buyers outnumbered sellers: 8 funds opened new NEPH positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Southpaw Asset Management, opening a new position worth an estimated $541K.
- 8 institutional investors held Nephros (NEPH) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $2.09M of Nephros stock for Q3 2019.
- 8 funds opened new Nephros positions in Q3 2019 and 0 closed out, a net change of +8 holders.
- The largest Nephros buyer in Q3 2019 was Southpaw Asset Management, an estimated $541K added.
Based on aggregated 13F filings for Q3 2019.